New Delhi | Jagran News Desk: Close to 138,600 people have volunteered in the US to participate in the clinical vaccine trial against COVID-19. The development takes place after Dr. Antony Fauci-led National Institute of Allergy and Infectious Diseases launched an initiative to sign up 120,000 volunteers to participate in a total of four efforts of developing a vaccine against COVID-19. Within two weeks of the launch of this effort, around 138,600 people from across the US came out to volunteer, Forbes reported.

Once a volunteer signs up, he/she is required to solve a questionnaire that basically evaluates the probability of them becoming infected with the virus, along with pre-existing physical conditions that must be known to the medical professional concerned.

The report says that there will be over a hundred testing sites across the US, with the possibility of international trials not completely ruled out. It further goes on to say that the volunteers will require to visit the testing center up to a prescribed point of time, but they will not be infected with the virus. A placebo or vaccine treatment on them will show whether the particular vaccine candidate is preventing the probability of them being infected or not.


"The trials aim to be as inclusive as possible and recruit multi-generational and multi-ethnic volunteers," a spokesperson of Fred Hutchinson Cancer Research Center was quoted as saying.

"While this early response is very gratifying, it is important to note that this is just a fraction of the number of people needed to participate in various trials and ensure adequate representation of various demographic categories," a spokesperson of National Institute of Allergy and Infectious Diseases was quoted as saying by Forbes.


Of 163 vaccine candidates that are under development worldwide, 26 vaccines are undergoing human clinical trials as of present.

Posted By: Shashikant Sharma